Advertisement
Screener

AGENUS INC (AGEN) Material Contracts, 2020

AGENUS INC Material Contracts

Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.

  • 2020-11-25: Form 8-K; Exhibit 10.1; Description Office Lease by and between Bay Center Investor LLC and Agenus Inc. dated November 25, 2020.
  • 2020-11-09: Form 10-Q; Exhibit 10.1; Description Executive Employment Agreement dated November 6, 2020, by and between Agenus Inc. and Evan Kearns. Filed herewith..
  • 2020-08-10: Form 10-Q; Exhibit 10.1; Description License and Collaboration Agreement, dated as of June 20, 2020, by and between Agenus Inc. and Betta Pharmaceuticals Co., Ltd. Filed herewith..
  • 2020-05-11: Form 10-Q; Exhibit 10.1; Description Consulting Agreement dated January 1, 2020 between Agenus Inc. and Brian Corvese. Filed herewith..
FiledFormExhibitDescription
2020-11-258-K10.1Office Lease by and between Bay Center Investor LLC and Agenus Inc. dated November 25, 2020
2020-11-0910-Q10.1Executive Employment Agreement dated November 6, 2020, by and between Agenus Inc. and Evan Kearns. Filed herewith.
2020-08-1010-Q10.1License and Collaboration Agreement, dated as of June 20, 2020, by and between Agenus Inc. and Betta Pharmaceuticals Co., Ltd. Filed herewith.
2020-05-1110-Q10.1Consulting Agreement dated January 1, 2020 between Agenus Inc. and Brian Corvese. Filed herewith.
2020-03-1610-K10.10.3Form of Restricted Stock Unit Award Agreement for the Agenus Inc. 2019 Equity Incentive Plan. Filed herewith.
2020-03-1610-K10.10.2Form of Non-Qualified Stock Option Agreement for the Agenus Inc. 2019 Equity Incentive Plan. Filed herewith.
2020-03-1610-K10.10.1Form of Incentive Stock Option Agreement for the Agenus Inc. 2019 Equity Incentive Plan. Filed herewith.

Similar stocks

Stock NameCountryMarket CapPE Ratio
C4 Therapeutics, Inc. (CCCC)United States$0.373B-5.65
FENNEC PHARMACEUTICALS INC. (FENC)United States$0.371B-115.85
Surrozen, Inc./DE (SRZN)United States$0.395B
Zura Bio Ltd (ZURA)$0.398B-6.56
Artiva Biotherapeutics, Inc. (ARTV)United States$0.367B
Cabaletta Bio, Inc. (CABA)United States$0.365B-2.81
Scribe Therapeutics, Inc. (SCTX)United States$0.410B
Ocugen, Inc. (OCGN)United States$0.343B-6.34
Editas Medicine, Inc. (EDIT)United States$0.424B-4.29
Kyverna Therapeutics, Inc. (KYTX)United States$0.434B-3.60